Skip to main content

New paradigms in whole genome sequencing: from lab bench to cell phone

The DNA sequencing & MDx fields have seen dramatic advances since the first draft of the human genome was published, with companies reporting ever faster and cheaper methods. However, despite the race to attain the $1000 genome producing a plethora of exciting technologies, capillary electrophoresis (CE) is still being routinely used for targeted clinical sequencing and expensive real time PCR devices are still the work-horse of the MDx laboratory. QuantuMDx is developing a portable, handheld DNA sequencing device for PGx and infectious disease applications, to provide an alternative to slow and relatively expensive CE DNA sequencing & expensive slow and lab based MDx & CDx.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jonathan O’Halloran.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Cite this article

O’Halloran, J. New paradigms in whole genome sequencing: from lab bench to cell phone. Mol Cytogenet 7 (Suppl 1), I27 (2014).

Download citation

  • Published:

  • DOI:


  • Infectious Disease
  • Genome Sequencing
  • Human Genome
  • Capillary Electrophoresis
  • Cell Phone